Status:
COMPLETED
International SARS-CoV-2 (COVID-19) Infection Observational Study
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
COVID
COVID19
Eligibility:
All Genders
18+ years
Brief Summary
The general aim of this study is to estimate the rate of disease progression for adults testing positive for SARS-CoV-2. The primary endpoint for this study and the basis for sample size is hospitaliz...
Detailed Description
SARS-CoV-2 is a coronavirus that emerged in China in late 2019 causing a novel Corona-Virus Induced Disease (COVID-19). COVID-19 is spreading rapidly throughout the world. While a proportion of people...
Eligibility Criteria
Inclusion
- \- Not currently hospitalized
Exclusion
- \- Persons with a known positive SARS-CoV-2 test \> 28 days ago
Key Trial Info
Start Date :
June 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
11973 Patients enrolled
Trial Details
Trial ID
NCT04385251
Start Date
June 18 2020
End Date
January 31 2022
Last Update
August 16 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Public Health
Denver, Colorado, United States, 80204
2
Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos
Buenos Aires, Argentina, C1221ADC
3
CHIP Department of Infectious Diseases
Copenhagen, Denmark
4
University College London Medical School Centre for Sexual Health and HIV Research
London, England, United Kingdom, WC1E